Kolexia
Montegut Coline
Oncologie médicale
Centre Paoli-Calmettes
Marseille, France
44 Activités
22 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Gliome Tumeurs de l'ovaire Carcinome pulmonaire non à petites cellules Fatigue Sarcopénie Complications postopératoires Fragilité Névralgie

Industries

Amgen
1 collaboration(s)
Dernière en 2023
Daiichi Sankyo
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Quality of life in older French long-term lung cancer survivors: VICAN5 national survey.
Lung cancer (Amsterdam, Netherlands)   20 avril 2023
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment.
Nutrients   27 février 2023
Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial.
European journal of cancer (Oxford, England : 1990)   10 décembre 2022
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade -Mutant Gliomas: A French POLA Network Study.
Cancers   09 novembre 2022
Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF).
Cancers   02 février 2022
Functional status in older patients with lung cancer: an observational cohort study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   15 janvier 2022
Prognostic Value of the B12/CRP Index in Older Systemically Treatable Cancer Patients.
Cancers   30 décembre 2021
1700P Functional status in older patients with lung and thoracic cancer
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
739P Efficacy and safety of maintenance olaparib and bevacizumab (bev) in ovarian cancer (OC) patients (pts) aged ≥65 years (y) from the PAOLA-1/ENGOT-ov25 first-line trial
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Older Patients Treated for Lung and Thoracic Cancers: Unplanned Hospitalizations and Overall Survival.
Clinical lung cancer   12 juin 2020